AstraZeneca Overturns $107 Million Pfizer Verdict in U.S. Patent DisputeOver Cancer Drug
A federal judge in Delaware on Wednesday ruled in favor of AstraZeneca, overturning a juryverdict that had ordered the company to pay $107.5 million for allegedly infringing oncancer-drug patents held by Pfizer subsidiary Wyeth.U.S. District
Read More